GEODE CAPITAL MANAGEMENT, LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 52 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$363,000
-19.7%
330,5860.0%0.00%
Q2 2020$452,000
+20.2%
330,5860.0%0.00%
Q1 2020$376,000
-80.1%
330,586
-60.1%
0.00%
Q4 2019$1,890,000
+444.7%
829,438
+101.6%
0.00%
Q3 2019$347,000
-14.7%
411,468
-1.4%
0.00%
Q2 2019$407,000
-29.9%
417,176
-9.6%
0.00%
Q1 2019$581,000
-78.7%
461,336
-45.2%
0.00%
Q4 2018$2,728,000
+340.0%
842,070
+226.9%
0.00%
Q3 2018$620,000
-4.6%
257,590
+10.5%
0.00%
Q2 2018$650,000
-18.5%
233,193
+38.7%
0.00%
Q1 2018$798,000
+96.1%
168,141
+140.3%
0.00%
Q4 2017$407,000
+154.4%
69,976
-8.3%
0.00%
Q3 2017$160,000
-55.2%
76,2920.0%0.00%
Q2 2017$357,000
-50.3%
76,292
-17.0%
0.00%
Q1 2017$718,000
-34.6%
91,936
+2.6%
0.00%
-100.0%
Q4 2016$1,098,000
+37.2%
89,565
+74.4%
0.00%
Q3 2016$800,000
+37.7%
51,358
+7.1%
0.00%
Q2 2016$581,000
+41.0%
47,955
+12.1%
0.00%
Q1 2016$412,00042,7770.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q2 2017
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders